Official announcements
Search narrowed by
messages in brief
|
10/05/2021
The EMA adopted the new recommendations for the composition of seasonal influenza vaccines for the season 2021/2022 (published 30 March 2021)
messages in brief
|
30/04/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
messages in brief
|
26/03/2021
National Vaccination Committee recommends extended dosage intervals for mRNA vaccines
messages in brief
|
19/03/2021
The Austrian Federal Office for Safety in Health Care (BASG) informs that the temporarily put on hold batch ABV 5300 of AstraZeneca's COVID 19 vaccine has been released again and can be vaccinated.
messages in brief
|
07/03/2021
Currently, there is no evidence of a causal relationship with vaccination.
messages in brief
|
25/02/2021
In cooperation with the pharmaceutical industry, the BASG has produced a guideline for processing DHPC (Direct Healthcare Professional Communication) and Educational Material.
messages in brief
|
03/02/2021
On 29. January 2021, "COVID-19 Vaccine AstraZeneca" was authorised in the European Union as the third vaccine against SARS-CoV2.
messages in brief
|
02/02/2021
To simplify the reporting of suspected adverse reactions of medicines and vaccines a revised online form is now available for patients.
messages in brief
|
29/01/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
messages in brief
|
22/01/2021
The United Kingdom has left the European Union and the transition period ended on 31 December 2020. This article gives a short overview about the current applicable rules.